{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:26:11Z","timestamp":1787235971957,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105555","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T12:55:47Z","timestamp":1710766547000},"page":"105555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement"],"prefix":"10.1016","volume":"85","author":[{"given":"Shanthi","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Vijayasingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Laurson-Doube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.L.","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrong","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mya Mya Aye","family":"Seinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohnmar","family":"Ohnmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riwanti","family":"Estiasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norazieda","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu Liong","family":"Hiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia T.T.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saysavath","family":"Keosodsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasitorn","family":"Siritho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigido Simao","family":"Dias de Deus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabani","family":"Remli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhailah","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-388X","authenticated-orcid":false,"given":"Su-Yin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2024.105555_bib0014","doi-asserted-by":"crossref","DOI":"10.1097\/MS9.0000000000000560","article-title":"Navigating the journey of multiple sclerosis management in Africa, overcoming hurdles and harnessing opportunities: a review","volume":"85","author":"Aderinto","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"12","key":"10.1016\/j.msard.2024.105555_bib0003","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2024.105555_bib0025","first-page":"35","article-title":"Health systems research volume 1: contextual analysis of the Malaysian health system","author":"Atun","year":"2016","journal-title":"Ministry Health Malaysia"},{"issue":"7","key":"10.1016\/j.msard.2024.105555_bib0016","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/heapol\/czs108","article-title":"Access to medicines from a health system perspective","volume":"28","author":"Bigdeli","year":"2012","journal-title":"Health Policy Plan"},{"issue":"6","key":"10.1016\/j.msard.2024.105555_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1017\/S0266462318003604","article-title":"Cost-utility analysis of multiple sclerosis treatment in Thailand","volume":"34","author":"Chanatittarat","year":"2018","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"10","key":"10.1016\/j.msard.2024.105555_bib0028","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s00415-022-11193-w","article-title":"Early use of high-efficacy disease\u2011modifying therapies makes the difference in people with multiple sclerosis: an expert opinion","volume":"269","author":"Filippi","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105555_bib0029","unstructured":"Gilson L, Alliance for Health Policy and Systems Research, World Health Organization. Health policy and systems research: a methodology reader \/edited by Lucy Gilson2012 2012. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/44803."},{"key":"10.1016\/j.msard.2024.105555_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420987031","article-title":"Health economics of disease-modifying therapy for multiple sclerosis in the United States","volume":"14","author":"Hartung","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2024.105555_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102510","article-title":"The current status and challenges in multiple sclerosis management in the Philippines","volume":"46","author":"Ignacio","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.105555_bib0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10728-009-0115-2","article-title":"Successful priority setting in low and middle income countries: a framework for evaluation","volume":"18","author":"Kapiriri","year":"2010","journal-title":"Health Care Anal."},{"issue":"3","key":"10.1016\/j.msard.2024.105555_bib0001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(19)30486-7","article-title":"Health-care disparities for people with multiple sclerosis","volume":"19","author":"Laurson-Doube","year":"2020","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2024.105555_bib0022","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/13524585211030207","article-title":"Ethical use of off-label disease-modifying therapies for multiple sclerosis","volume":"27","author":"Laurson-Doube","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2024.105555_bib0020","unstructured":"Multiple Sclerosis International Federation. Atlas of MS, 3rd ed. Proportion of people with MS treated with DMTs. 2020 [Available from: https:\/\/www.atlasofms.org\/chart\/indonesia\/disease-modifying-treatments\/proportion-of-people-with-ms-treated-with-dmts] [Accessed: March 15, 2023]."},{"key":"10.1016\/j.msard.2024.105555_bib0024","unstructured":"Multiple Sclerosis International Federation. Atlas of MS, 3rd ed. Types of DMT used to treat MS. 2020 [Available from: https:\/\/www.atlasofms.org\/table\/indonesia\/disease-modifying-treatments\/types-of-dmt-used-to-treat-ms] [Accessed: March 15, 2023]."},{"key":"10.1016\/j.msard.2024.105555_bib0004","unstructured":"Multiple Sclerosis International Federation. Atlas of MS, 3rd ed. 2020."},{"issue":"1","key":"10.1016\/j.msard.2024.105555_bib0037","first-page":"41","article-title":"Resources and organization of neurology care in South East Asia","volume":"12","author":"Poungvarin","year":"2007","journal-title":"Neurol. Asia"},{"issue":"5","key":"10.1016\/j.msard.2024.105555_bib0030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1377\/hlthaff.2015.0863","article-title":"Improving health care coverage, equity, and financial protection through a hybrid system: Malaysia's experience","volume":"35","author":"Rannan-Eliya","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.msard.2024.105555_bib0012","doi-asserted-by":"crossref","unstructured":"Rojas JI, Carnero Contentti E, Abad P, Aguayo A, Alonso R, Bauer J, et al. Research priorities in multiple sclerosis in Latin America: a multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Multiple Sclerosis and Related Disorders. 2021;53:103038. 10.1016\/j.msard.2021.103038.","DOI":"10.1016\/j.msard.2021.103038"},{"issue":"4","key":"10.1016\/j.msard.2024.105555_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/epi4.12432","article-title":"Availability, affordability, and quality of essential antiepileptic drugs in Lao PDR","volume":"5","author":"Sengxeu","year":"2020","journal-title":"Epilepsia Open"},{"issue":"10","key":"10.1016\/j.msard.2024.105555_bib0015","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A Consensus-Based Checklist for Reporting of Survey Studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.msard.2024.105555_bib0006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.msard.2018.07.004","article-title":"Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand","volume":"24","author":"Siritho","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105555_bib0034","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jmir.2022.10.170","article-title":"Current situation of magnetic resonance imaging services in Indonesia","volume":"53","author":"Sugiyanto","year":"2022","journal-title":"J. Med. ImAging Radiat. Sci."},{"issue":"4","key":"10.1016\/j.msard.2024.105555_bib0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ncn3.12479","article-title":"Central nervous system inflammatory demyelinating diseases and neuroimmunology in Singapore\u2014epidemiology and evolution of an emerging subspecialty","volume":"9","author":"Tan","year":"2021","journal-title":"Neurol. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.msard.2024.105555_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S1474-4422(19)30390-4","article-title":"Essential medicines for patients with multiple sclerosis","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.105555_bib0018","first-page":"70","article-title":"The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study","author":"Tisavipat","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105555_bib0036","unstructured":"Traicharoenwong C. Magnetic Resonance Imaging (MRI) in Thailand, amount 220 machines 2022 [updated 25\/08\/2022. Available from: https:\/\/neuronetworks.org\/?p=2704] [Accessed: December 8, 2022]."},{"issue":"1","key":"10.1016\/j.msard.2024.105555_bib0002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1352458518797290","article-title":"A call for more research and global collaboration in South-East Asia to address challenges of DMT access and MS management in the region","volume":"25","author":"Vijayasingham","year":"2019","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2024.105555_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09581596.2017.1403011","article-title":"Challenges for accessing and financing high-cost medicines in multipayer systems: case studies of multiple sclerosis in Malaysia","volume":"29","author":"Vijayasingham","year":"2017","journal-title":"Crit. Public Health"},{"key":"10.1016\/j.msard.2024.105555_bib0027","doi-asserted-by":"crossref","first-page":"m3384","DOI":"10.1136\/bmj.m3384","article-title":"Employment based health financing does not support gender equity in universal health coverage","volume":"371","author":"Vijayasingham","year":"2020","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.msard.2024.105555_bib0019","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/1352458518792430","article-title":"A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia","volume":"25","author":"Viswanathan","year":"2019","journal-title":"Mult. Scler. J."},{"issue":"3","key":"10.1016\/j.msard.2024.105555_bib0023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1744-9987.12806","article-title":"Proceedings of the inaugural strategy meeting for the establishment of a Southeast Asia regional therapeutic plasma exchange consortium for neurological disorders","volume":"23","author":"Viswanathan","year":"2019","journal-title":"Therapeut. Apheres. Dialysis: Off. Peer-Reviewed J. Int. Soc. Apheres., Japanese Soc. Apheres., Japanese Soc. Dialysis Ther."},{"issue":"3","key":"10.1016\/j.msard.2024.105555_bib0032","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.105555_bib0031","unstructured":"World Health Organization. Regional office for South-East Asia. Improving access to medicines in the South-East Asia Region: progress, challenges, priorities. New Delhi: World Health Organization. Regional Office for South-East Asia; 2017 2017-08."},{"key":"10.1016\/j.msard.2024.105555_bib0008","unstructured":"World Health Organization. Intersectoral global action plan on epilepsy and other neurological disorders 2022-2031. 2021 5 March 2021."},{"key":"10.1016\/j.msard.2024.105555_bib0009","doi-asserted-by":"crossref","unstructured":"World Health Organization. Model List of Essential Medicines - 23rd List: World Health Organization, Geneva; 2023. 67 p.","DOI":"10.1530\/ey.19.13.1"},{"key":"10.1016\/j.msard.2024.105555_bib0013","first-page":"79","article-title":"Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: a regional survey-based study","author":"Zeineddine","year":"2023","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:41:14Z","timestamp":1738046474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"alternative-id":["S2211034824001342"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105555","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105555"}}